Key Takeaways
- The “Protein Engineering for Pharmaceutical Biotechnology Training Course” will take place on January 21-22, 2026.
- Attendees will gain expertise in developing protein-based therapeutics, critical in advancing modern medicine.
- The course is suitable for professionals in biotechnology, regulatory affairs, clinical research, and related fields.
Course Overview
A new training course on Protein Engineering for Pharmaceutical Biotechnology is scheduled for January 21-22, 2026. This course aims to enhance knowledge in protein engineering, a vital area for the advancement of therapeutic development and industrial applications. Protein-based therapies have made significant strides, with half of the top ten selling drugs in 2023 classified as such.
Protein engineering combines nature’s billions of years of evolution with modern laboratory techniques to create customized proteins, particularly enzymes for diverse pharmaceutical uses. This course equips professionals with essential skills in molecular biology, protein chemistry, and structural chemistry to develop effective solutions tailored for the pharmaceutical sector.
The importance of this training is underlined by its recognition in the scientific community, notably the 2018 Nobel Prize in Chemistry, awarded for groundbreaking advancements in the field. Participants will deepen their understanding of relevant concepts while staying updated on crucial advancements such as CRISPR-Cas9 gene editing and mRNA therapeutics.
Course Benefits
– Participants will acquire a profound understanding of protein engineering, enhancing expertise in areas including molecular biology and enzymology.
– The curriculum covers the latest techniques, like CRISPR and phage display, as well as applications in developing innovative therapeutics, including various types of antibodies and vaccines.
– Insights into biotechnology applications, from genetically modified organisms (GMOs) to directed evolution for enzyme production, will be provided.
Target Audience
The course is ideal for those with a foundation in biochemistry and molecular biology. It caters to biotechnology professionals, regulatory affairs staff, pharmaceutical development specialists, and clinical researchers, among others.
Course Structure
The course spans two days, covering a range of topics. Day one includes an introduction to protein engineering, techniques in genetic engineering, and therapeutic applications such as monoclonal antibodies and gene therapy. Key methodologies such as recombinant DNA technology and RNA interference will also be explored.
Day two addresses ethical and regulatory considerations, advancements in gene editing therapies, and challenges in protein engineering. Case studies on successful therapeutic applications, including insulin production and CAR-T cancer therapy, will be discussed.
Participants will receive a certificate of completion and 12 hours of CPD credit. For more information, visit ResearchAndMarkets.com.
The content above is a summary. For more details, see the source article.